Journal
CANCER TREATMENT REVIEWS
Volume 41, Issue 1, Pages 1-8Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.ctrv.2014.10.008
Keywords
Hereditary breast cancer; Breast cancer susceptibility genes; TP53; PTEN; PALB2
Categories
Ask authors/readers for more resources
Approximately 5-10% of breast cancer cases might be inheritable, up to 30% of which are due to BRCA1/2 mutations. During the past few years and thanks to technology evolution, we have been witnesses of an intensive search of additional genes with similar characteristics, under the premise that successful gene discovery will provide substantial opportunities for primary and secondary prevention of breast cancer. Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2. This review will summarize current data on new findings in breast cancer susceptibility genes. (C) 2014 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available